Large SUVs Market Size Worth $334.3 Billion By 2028

 May 2022 | Report Format: Electronic (PDF)

Large SUVs Market Growth & Trends

The global large SUVs market size is expected to reach USD 334.3 billion by 2028, registering a CAGR of 0.5% from 2022 to 2028, according to a new report by Grand View Research, Inc. The market growth of the large SUVs is significantly driven by the increasing popularity pertaining to the characteristics of on-road passenger cars and off-road sport vehicles. The rising popularity among car consumers in Europe, the Middle East, China, and India are expected to drive the market growth. Other characteristics such as large storage and seating space, higher ground clearance for mountain terrains, higher vantage point, etc. attracts consumers fueling the market growth. Furthermore, the introduction of an electric version of large SUVs is likely to propel market growth. For instance, as published on 17th November 2021, Hyundai revealed a new extra-large electric SUV, Hyundai Seven at Los Angeles Auto show.

The market growth of the large SUVs experienced a negative impact during the COVID-19 pandemic outbreak. To curb the infection, lockdowns and restrictions were imposed by the governments worldwide, which disrupted the supply chain at various stages in the automotive industry. This ultimately affected the global output of the large SUVs as well as worldwide sales, plummeting the growth rate. Over the forecast period, the market is expected to recover with resumed manufacturing, product launches, and purchase activities.

The electric segment by fuel type is anticipated to show strong growth scenarios, owing to the government initiatives, increased product launches, phasing out of fossil fuels, and environmental policies. From 2022 to 2028, the electric segment is expected to register a CAGR of 11.1% in the global market. Many carmakers are phasing out petrol and diesel cars and plan to go all-electric vehicles in the future. For instance, at United Nations, Climate Change Conference 2021, held in Oct.-Nov. 2021, major countries and automakers have set a new goal to go all-electric by 2040. The list of automakers comprises Ford, General Motors, Volvo, and Jaguar Land Rover, among others.

North America dominated the global market in 2021. The U.S. market being the biggest consumer and demanding region for large SUVs. The shift in consumer preference in the U.S. for off-road utility vehicles and increased popularity is credited for the higher consumption rate. Furthermore, the strong presence of the key players, easy availability, and higher spending on the passenger vehicles in the region are attributable to higher market revenue share.

---

 Request a free sample copy or view report summary: Large SUVs Market Report

---

Large SUVs Market Report Highlights

• Europe is expected to witness the highest growth rate over the forecast period, registering a CAGR of 1.1% from 2022 to 2028. Heightened product launches, increasing popularity, and increasing spending on the passenger vehicles are expected to drive the regional market growth

• The petrol segment held the highest share and is expected to maintain its dominance over the coming years. Easy availability, easy maintenance and aftersales service, easy accessibility of replacement parts, huge product offerings credited to the higher market share

• Electric segment is pegged to register a CAGR of 11.1% from 2022 to 2028. The segment growth is attributed to the government initiatives to lower the greenhouse gas emission and manufactures increased product launches

Large SUVs Market Segmentation

Grand View Research has segmented the large SUVs market based on fuel type, and region:

Large SUVs Fuel Type Outlook (Revenue, USD Million, 2017 - 2028)

• Petrol

• Diesel

• Electric

• Others

Large SUVs Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America

  • U.S.

  • Canada

• Europe

  • Germany

  • U.K.

  • France

  • Russia

  • Italy

• Asia Pacific

  • China

  • Japan

  • India

• Central & South America

  • Brazil

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

List of Key Players of Large SUVs Market

• Stellantis NV

• Toyota Motor

• Renault

• Volkswagen

• Hyundai Motor Company

• Volvo Car Corporation

• Suzuki Motor Corporation

• General Motors

• Ford Motor Company

• BMW Group

• Peugeot S.A.

• Geely

Dust Control Systems Market Worth $20.3 Billion By 2025 | CAGR: 4.2%

 November 2019 | Report Format: Electronic (PDF)

The global dust control systems market size is expected to reach USD 20.3 billion by 2025, according to a new report by Grand View Research, Inc., registering a CAGR of 4.2% over the forecast period. The demand for the product is primarily driven by increasing air pollution and growing awareness pertaining to the benefits of dust control systems, coupled with rising health concerns.

The need for clean air is increasing with rising pollution levels, coupled with growing respiratory issues in urban areas, which is expected to contribute significantly to the growth of the market. Increasing need for adoption of the product, especially in developing regions across the globe, is anticipated to drive demand over the forecast period.

Increase in global construction activities and growing demand for high-quality construction materials are expected to drive the cement manufacturing sector. Cement manufacturing is one of the largest end-use industries for the product, thereby boosting the growth of dust control systems market substantially over the forecast period.

Product manufacturers are investing heavily on research and development activities in order to develop highly efficient and technologically advanced systems. Furthermore, governments across the regions are introducing stringent regulations and standards to regulate increasing air pollution, which, in turn, is expected to boost product demand over the forecast period.

 To request a sample copy or view summary of this report, click the link below:
https://www.grandviewresearch.com/industry-analysis/dust-control-systems-market

Further key findings from the report suggest

• The wet product segment accounted for the largest share in the global dust control systems market in 2018 and the segment is also projected to register the highest CAGR of 4.3% from 2019 to 2025. The segment is sub-segmented into wet electrostatic precipitators and wet scrubbers

• The construction segment was valued at USD 3.1 billion in 2018 and is likely to witness growth over the forecast period owing to increasing penetration of the systems in construction activities in developing economies such as China, India, and Brazil

• Asia Pacific emerged as the leading regional market and accounted for a share of 37.1% in the overall market in 2018 owing to growing construction and mining activities in China and India

• Europe accounted for the second-largest revenue share in 2018 owing to technological developments and stringent government regulations pertaining to reducing air pollution

• Advanced research and development operations of market participants have led to extremely innovative designs, which have optimized product adoption across the globe. 

Grand View Research has segmented the global dust control systems market on the basis of product, end use, and region:

Dust Control Systems Product Outlook (Revenue, USD Million, 2014 - 2025)

• Wet

• Wet scrubbers

• Wet electrostatic precipitators (WEPS)

• Dry

• Bag Dust Collectors

• Cyclone Dust Collectors

• Electrostatic Dust Collectors

• Vacuum Dust Collectors

• Others

Dust Control Systems End-use Outlook (Revenue, USD Million, 2014 - 2025)

• Construction

• Mining

• Oil & gas

• Chemical

• Food & beverage

• Pharmaceutical

• Others

Dust Control Systems Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America

• U.S.

• Canada

• Mexico

• Europe

• Germany

• France

• Italy

• U.K.

• Asia Pacific

• China

• Japan

• India

• Australia

• Central & South America

• Brazil

• Argentina

• Middle East & Africa

• Saudi Arabia

• United Arab Emirates

Continuous Manufacturing Market In Pharmaceuticals & Biopharmaceuticals Worth $2.3 Billion By 2027

 January 2025 | Report Format: Electronic (PDF)

Continuous Manufacturing Market In Pharmaceuticals & Biopharmaceuticals Growth & Trends

The global continuous manufacturing market in pharmaceuticals and biopharmaceuticals size is expected to reach USD 2.3 billion by 2027, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 13.85% from 2021 to 2027. Although batch manufacturing is the dominant mode of product development within the pharma and biopharma industry, the companies have begun shifting their focus toward continuous manufacturing (CM). The key drivers for the transition from batch to continuous manufacturing include drug shortage, more stringent requirements for consistent quality, the need for reduced processing costs, and the demand for higher and improved productivity.

Regulatory authorities are increasingly supportive of this therapeutic development model. They are encouraging the adoption of CM through releasing drafts and guidelines. Moreover, the presence of communities and organizations that are devoted to the commercialization of this market within the pharma and biopharma sector is driving the revenue. CCP Summit 2020 is one of such summits that is engaged in exploring scientific and technological advancements to address the technology challenges and accelerate upfront investment in the market.

In addition, the growing demand for biosimilars and an ever-increasing pressure for reducing drug development costs have driven the interest of biopharma players in this space. With a plethora of research activities available on making individual unit operations continuous, studies are also conducted to explore the possibility of a continuous end-to-end development process. Ongoing research efforts in this area are anticipated to greatly favor the revenue growth in the coming years.

Based on mode, in-house pharmaceutical companies are anticipated to witness lucrative growth in the coming years owing to the shift of well-established pharma players toward the continuous manufacturing market. On the basis of scale, the clinical and preclinical scale manufacturing segments collectively captured a significant revenue share in 2020 owing to the easy integration of systems and a high number of ongoing R&D activities.

North America led the global market in 2020. This is attributed to the presence of key technology developers as well as high R&D expenditure in drug development by the end-users in the U.S. Key players are implementing various strategies to strengthen their product offerings and offer diverse technologically advanced products to accelerate therapeutics development.

Request a free sample copy or view report summary:
Continuous Manufacturing Market In Pharmaceuticals & Biopharmaceuticals Report

Continuous Manufacturing Market In Pharmaceuticals & Biopharmaceuticals Report Highlights

• In terms of therapeutics type, the pharmaceutical/small molecules segment dominated the market in 2020 owing to high technology penetration in this segment. The biopharmaceutical/large molecules segment is anticipated to witness lucrative growth owing to increasing investment in facility expansion to integrate CM systems
• On the basis of application, finished product manufacturing led the market in 2020 owing to the established use of CM in finished product development due to the commercial cost and time-saving advantages of technology
• By formulation, solid formulation dominated the market in 2020 owing to the maximum adoption of CM methodologies in solid drug production
• Based on mode, the contract segment led the market in 2020 due to the ongoing demand, coupled with the increasing popularity of contract services. The increasing investment in biosimilars production is expected to spur the use of CM technology within contract manufacturing organizations
• By product, semi-continuous systems accounted for the maximum revenue share in 2020 owing to the increasing adoption of a hybrid model of manufacturing within small to medium-sized drug developers as well as major pharma companies

Continuous Manufacturing Market In Pharmaceuticals & Biopharmaceuticals Segmentation

Grand View Research has segmented the global continuous manufacturing market in pharmaceuticals and biopharmaceuticals on the basis of therapeutics type, application, formulation, mode, scale, product, and region:

Continuous Manufacturing Market In Pharmaceuticals & Biopharmaceuticals Therapeutics Type Outlook (Revenue, USD Million, 2016–2027)

• Large Molecules
• Small Molecules

Continuous Manufacturing Market In Pharmaceuticals & Biopharmaceuticals Application Outlook (Revenue, USD Million, 2016–2027)

• Finished Product Manufacturing
• API Manufacturing

Continuous Manufacturing Market In Pharmaceuticals & Biopharmaceuticals Formulation Outlook (Revenue, USD Million, 2016–2027)

• Solid Formulation
• Liquid & Semi-solid Formulation

Continuous Manufacturing Market In Pharmaceuticals & Biopharmaceuticals Mode Outlook (Revenue, USD Million, 2016–2027)

• In-house
• Contract

Continuous Manufacturing Market In Pharmaceuticals & Biopharmaceuticals Scale Outlook (Revenue, USD Million, 2016–2027)

• Preclinical
• Clinical
• Commercial

Continuous Manufacturing Market In Pharmaceuticals & Biopharmaceuticals Product Outlook (Revenue, USD Million, 2016–2027)

• Integrated Systems
• Semi-continuous Systems
• Continuous Granulators
• Continuous Blenders
• Continuous Compressors
• Continuous Coaters
• Continuous Dryers
• Other Semi-continuous Systems
• Others

Continuous Manufacturing Market In Pharmaceuticals & Biopharmaceuticals Regional Outlook (Revenue, USD Million, 2016–2027)

• North America
• U.S.
• Canada
• Europe
• Germany
• U.K.
• Spain
• France
• Italy
• Asia Pacific
• Japan
• China
• India
• South Korea
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• South Africa
• Saudi Arabia

List of Key Players of Continuous Manufacturing Market in Pharmaceuticals & Biopharmaceuticals

• Thermo Fisher Scientific, Inc.
• Pall Corporation
• Applikon Biotechnology
• Sartorius Stedim Biotech
• GEA Group Aktiengesellschaft
• Corning Incorporated
• Merck KGaA
• Glatt GmbH
• Repligen Corporation
• Eppendorf AG
• Electrolab Biotech Ltd.
• Solesis Medical
• Scott Equipment Company
• L.B. Bohle
• LONZA
• 3M
• CellGenix GmbH
• Boehringer Ingelheim International GmbH
• Bio-Rad Laboratories
• Avantor, Inc.
• Ajinomoto Bio-Pharma
• GlaxoSmithKline
• Continuus Pharmaceuticals
• Arcinova
• Amgen

Spandex Market Size Worth $8.8 Billion By 2027 | CAGR 2.2%

 January 2025 | Report Format: Electronic (PDF)

Spandex Market Growth & Trends

The global spandex market size is expected to reach USD 8.8 billion by 2027 registering a CAGR of 2.2%, according to a new report by Grand View Research, Inc. Rapid expansion of the textile industry coupled with rising demand for sportswear, active wear, diapers, intimate wear, etc. is projected to propel the market growth. Benefits of spandex fibers including lightweight, resistance to perspiration, superior elasticity, excellent strength, and durability are projected to promote its use in applications including clothing, medical, and others.

Spandex is increasingly being used in the manufacturing of medical products including compress bandages, stretchable bandages, surgical hose, etc. Rising demand for medical products across the globe on account of the increasing number of healthcare centers is expected to augment the product demand further. Raw materials used in the manufacturing of spandex include Polytetramethylene Ether Glycol (PTEG) and MDI that are derived from petrochemical feedstock. Stringent government regulations across the economies to curb the carbon footprints is projected to limit the expansion of the spandex market.

Request a free sample copy or view report summary:
Spandex Market Report

Spandex Market Report Highlights

• The clothing application segment is projected to register the fastest CAGR from 2020 to 2027 on account of the growing demand for sportswear, swimwear, yoga pants, under garments, and others
• The solution dry-spinning process accounted for the maximum market share of 95.2% in 2019 and is projected to register at a steady CAGR from 2020 to 2027 owing to the multiple benefits of the process including higher spinning speed and flexibility
• Asia Pacific led the global market in 2019 owing to the expansion of textile industry in China, India, Indonesia, and several other economies
• Growing production of spandex in U.S. on account of the rising demand for active wear, sportswear, inner wear, and others is projected to drive the North America regional market
• China accounted for the highest market share in Asia Pacific due to the growing number of production facilities in the country

Spandex Market Segmentation

Grand View Research has segmented the global spandex market on the basis of application, technology, and region:

Spandex Application Outlook (Volume, Kilotons; Revenue, USD Million, 2016–2027)

• Clothing
• Medical
• Others

Spandex Technology Outlook (Volume, Kilotons; Revenue, USD Million, 2016–2027)

• Solution Dry-spinning
• Wet-spinning
• Others

Spandex Regional Outlook (Volume, Kilotons; Revenue, USD Million, 2016–2027)

• North America
• U.S.
• Canada
• Mexico
• Europe
• Germany
• U.K.
• Spain
• Italy
• Asia-Pacific
• China
• India
• Japan
• Central & South America
• Brazil
• Middle East & Africa

List of Key Players of Spandex Market

• Hyosung
• DuPont de Nemours, Inc.
• Taekwang Industrial Co. Ltd.